Corticosteroids and the Treatment of Idiopathic Pulmonary Fibrosis
Open accessThe DOI matches its Crossref record.
Abstract
Why are corticosteroids used in patients with IPF? There is evidence that corticosteroid therapy is associated with clinical improvement in only a small percentage of IPF patients. This improvement is seen primarily in patients with a cellular histologic pattern on lung biopsy specimens, but no clinical, physiologic, or pathologic finding has been consistently associated with corticosteroid response. For IPF patients with a fibrotic histologic pattern on lung biopsy specimens, there is little evidence that corticosteroids are of any benefit, and available reports suggest that the cost of therapy in terms of both morbidity and mortality may be high. Little is known about the effect of corticosteroids on long-term clinical outcomes, and even less is known about their effects on the overall quality of life. Although current treatment regimens are based on the rationale that IPF is due to alveolar inflammation, which is probably an accurate assumption, the treatment to suppress the alveolitis should have an outcome that patients consider favorable. Data from the New Mexico ILD Registry and from other researchers suggest that the paucity of useful clinical data in IPF has resulted in a hodgepodge of diagnostic approaches and therapeutic criteria, as well as a fatalistic approach to treatment. Medical history is replete with examples of failed therapies. Analogies can be drawn between the history of IPF treatment and other catastrophic illnesses. 67 The common threads in all poorly treatable diseases are a lack of understanding about the cause and pathophysiologic state of the illness, an emphasis on indirect encouraging evidence about therapy instead of direct discouraging evidence, and the physician's ever-present compulsion to "do something." What we should learn from these examples is that when clearly effective therapies are not available, we are ethically obligated to give patients full information about the faults and merits of what is available and to assist them in choosing what is best for them. Medicine has advanced in the past only when assumptions about diseases and treatments were examined critically; we must continue to challenge our assumptions about IPF and corticosteroid therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
Interstitial lung disease guideline
Wells, A. U., Hirani, N., & on behalf of the BTS Interstitial Lung Disease Guideline Group, A. S. O. T. B. T. S. S. O. C. C. (2008) · Thorax · doi:10.1136/thx.2008.101691 · Cited by 866
Prognostic Value of Desaturation during a 6-Minute Walk Test in Idiopathic Interstitial Pneumonia
Lama, V. N., Flaherty, K. R., Toews, G. B., Colby, T. V., Travis, W. D., Long, Q., Murray, S., Kazerooni, E. A., Gross, B. H., Lynch, J. P., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200302-219oc · Cited by 555
Metadata
- Authors
- Mapel, D. W., Samet, J. M., & Coultas, D. B.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 1996-10
- Volume
- 110
- Issue
- 4
- Pages
- 1058-1067
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W1995929778
- Cited by
- 146
- References
- 0
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Corticosteroids and the Treatment of Idiopathic Pulmonary Fibrosis. https://app.cochat.ai/papers/10.1378/chest.110.4.1058
- The paper
- Mapel, D. W., Samet, J. M., & Coultas, D. B. (1996). Corticosteroids and the Treatment of Idiopathic Pulmonary Fibrosis. Chest. https://doi.org/10.1378/chest.110.4.1058
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.